The underlying technology, patent rights and improvements have been exclusively licensed from McLean Hospital, the largest psychiatric facility at the Harvard Medical School, which is an affiliate of Massachusetts General Hospital and a member of the Partners Healthcare System.
The inventor of the Quotient™ ADHD System1 is Martin H. Teicher, M.D., Ph.D., who has been Director of the Developmental Biopsychiatry Research Program at McLean Hospital, since 1988. For more than a decade, Dr. Teicher has served as Director of McLean Hospital’s Clinical Chronobiology Laboratory and is an Associate Professor of Psychiatry at Harvard Medical School. He is active on the Editorial Board of the Journal of Child and Adolescent Psychopharmacology and is a member of Harvard University’s Brain Development Working Group. Dr. Teicher received his Bachelor of Science degree from Rensselaer Polytechnic Institute, a Ph.D. with highest distinction from The Johns Hopkins University, and an M.D. from Yale University School of Medicine. He has chaired the National Institute of Mental Health’s special Review Committee on computer applications in mental health, has published more than 100 articles, and has received numerous honors, including the Merck Award for Outstanding Academic Achievement. Dr. Teicher’s recent work has uncovered some of the biological roots of ADHD. Dr. Teicher is a member of the Scientific Advisory Board for BioBDx.
1. The Quotient™ ADHD System was formerly known as the MMAT/ADHD™ System.
How the Quotient™ ADHD System Works